Cenk Tek, MD
Psychiatry
Telehealth is available
Patient type treated
Adult
Accepting new patients
No
Referral required
MD to MD Consult
Biography
Cenk Tek, MD, is a psychiatrist with a focus on treating individuals with psychotic disorders. He specializes in treating conditions such as schizophrenia and bipolar disorder, providing a comprehensive range of treatments that include medication management and psychosocial interventions designed to stabilize symptoms and promote long-term recovery.
Dr. Tek’s research involves exploring the most effective treatments for psychotic disorders. He has been involved in developing and refining early intervention services for individuals experiencing their first episode of psychosis, and he works on improving clinical outcomes for these patients.
Dr. Tek received his medical training from Hacettepe University Faculty of Medicine in Turkey. He completed his residency and psychiatry fellowship at Yale School of Medicine.
Titles
- Professor of Psychiatry
- Director, Psychosis Program, CMHC
Education & Training
- MDHacettepe University Faculty of Medicine (1991)
Languages Spoken
- English
- Türkçe (Turkish)
Additional Information
Publications
- Grilo C, Ivezaj V, Tek C, Yurkow S, Wiedemann A, Gueorguieva R. Cognitive Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge-Eating Disorder With Obesity: A Randomized Controlled Trial. American Journal Of Psychiatry 2024 PMID: 39659158, DOI: 10.1176/appi.ajp.20230982.
- Grilo C, Ivezaj V, Yurkow S, Tek C, Wiedemann A, Gueorguieva R. Lisdexamfetamine maintenance treatment for binge-eating disorder following successful treatments: randomized double-blind placebo-controlled trial. Psychological Medicine 2024, 54: 3334-3344. PMID: 39258475, PMCID: PMC11496227, DOI: 10.1017/s003329172400148x.
- Hazan H, Ferrara M, Riley S, Li F, Zhou B, Kline E, Gibbs-Dean T, Karmani S, Tayfur S, Tek C, Keshavan M, Srihari V. The impact of early detection (ED) campaigns on care presentations: Beyond DUP reduction. Schizophrenia Research 2024, 264: 457-461. PMID: 38266513, PMCID: PMC10923115, DOI: 10.1016/j.schres.2024.01.022.
- Ferrara M, Guloksuz S, Hazan H, Li F, Tek C, Sykes L, Riley S, Keshavan M, Srihari V. The effect of duration of untreated psychosis (DUP) on the risk for hospitalization after admission to a first episode service. Schizophrenia Research 2023, 260: 198-204. PMID: 37688984, DOI: 10.1016/j.schres.2023.08.005.
- Srihari V, Ferrara M, Li F, Kline E, Gülöksüz S, Pollard J, Cahill J, Mathis W, Sykes L, Walsh B, McDermott G, Seidman L, Gueorguieva R, Woods S, Tek C, Keshavan M. Corrigendum to: Reducing the Duration of Untreated Psychosis (DUP) in a US Community: A Quasi-Experimental Trial. Schizophrenia Bulletin Open 2022, 3: sgac020. PMID: 39144776, PMCID: PMC11206056, DOI: 10.1093/schizbullopen/sgac020.
- Srihari V, Ferrara M, Kline E, Li F, Burke S, Cahill J, Guloksuz S, Woods S, Tek C, Keshavan M. O1.2. REDUCING THE DURATION OF UNTREATED PSYCHOSIS IN A U.S. CATCHMENT: THE MINDMAP CAMPAIGN. Schizophrenia Bulletin 2020, 46: s1-s1. PMCID: PMC7233978, DOI: 10.1093/schbul/sbaa028.001.
- Choi J, Taylor B, Fiszdon J, Astur R, Haber L, Shagan D, Tek C, Kurtz M, Pearlson G. 31.1 COMBINING EXERCISE PHYSIOLOGY, RECREATIONAL THERAPY, VIRTUAL REALITY GAMING TECHNOLOGY, AND PSYCHOSOCIAL REHABILITATION TO PROMOTE PHYSICAL EXERCISE IN SERIOUS MENTAL ILLNESS. Schizophrenia Bulletin 2019, 45: s139-s140. PMCID: PMC6455379, DOI: 10.1093/schbul/sbz022.127.
- Kucukgoncu S, Guloksuz S, Tek C. Effects of Curcumin on Cognitive Functioning and Inflammatory State in Schizophrenia. Journal Of Clinical Psychopharmacology 2019, 1. DOI: 10.1097/00004714-900000000-98602.
- Kucukgoncu S, Zhou E, Lucas K, Tek C. Alpha‐lipoic acid (ALA) as a supplementation for weight loss: results from a meta‐analysis of randomized controlled trials. Obesity Reviews 2017, 18: 594-601. PMID: 28295905, PMCID: PMC5523816, DOI: 10.1111/obr.12528.
- Srihari V, Guloksuz S, Li F, Tek C, Woods S, Pollard J, Cahill J, Keshavan M, Seidman L. 178.3 Mindmap: A Population-Based Approach to Early Detection of Psychosis in the United States. Schizophrenia Bulletin 2017, 43: s95-s95. PMCID: PMC5475714, DOI: 10.1093/schbul/sbx021.255.
- Choi J, Taylor B, Tek C, Kurtz M, Fiszdon J, Thime W, Dewberry M, Haber L, Assaf M, Pearlson G. 207. The Synergistic Effects of Physical and Cognitive Exercise in Schizophrenia. Schizophrenia Bulletin 2017, 43: s106-s106. PMCID: PMC5475743, DOI: 10.1093/schbul/sbx021.285.
- Annamalai A, Tek C, Sernyak M, Cole R, Steiner J. Integrated Health Care. 2016, 63-80. DOI: 10.1093/med/9780190214678.003.0005.
- Pollard J, Tek C, Woods S, McGlashan T, Srihari V. Early Intervention and Prevention for Psychotic Disorders. 2016, 155-170. DOI: 10.1093/med/9780190214678.003.0010.
- Ratliff J, Reutenauer E, Tek C. Managing Medication Effects on Body Weight: Do Behavioral Interventions Work? FOCUS The Journal Of Lifelong Learning In Psychiatry 2012, 10: 130-139. DOI: 10.1176/appi.focus.10.2.130.
- Tek C, Ratliff J, Chwastiak L. Pharmacological Treatment of Obesity. Psychiatric Annals 2011, 41: 489-495. DOI: 10.3928/00485713-20110921-08.
- Ratliff J, Palmese L, Reutenauer E, Liskov E, Tek C. Individuals with schizophrenia consume more calories while following a similar diet pattern as the general population. The FASEB Journal 2011, 25: 991.1-991.1. DOI: 10.1096/fasebj.25.1_supplement.991.1.
- Srihari V, Breitborde N, Pollard J, Tek C, Hyman L, Frisman L, McGlashan T, Jacobs S, Woods S. Public-Academic Partnerships: Early Intervention for Psychotic Disorders in a Community Mental Health Center. Psychiatric Services 2009, 60: 1426-1428. DOI: 10.1176/ps.2009.60.11.1426.
- Chwastiak LA, Tek C. The unchanging mortality gap for people with schizophrenia. The Lancet 2009, 374: 590-592. PMID: 19595448, DOI: 10.1016/s0140-6736(09)61072-2.
- Jean-Baptiste M, Tek C, Liskov E, Chakunta UR, Nicholls S, Hassan AQ, Brownell KD, Wexler BE. A pilot study of a weight management program with food provision in schizophrenia. Schizophrenia Research 2007, 96: 198-205. PMID: 17628437, DOI: 10.1016/j.schres.2007.05.022.
- Schizophrenia: Clinical Features and Psychopathology ConceptsKirkpatrick B, Tek C. Schizophrenia: Clinical Features and Psychopathology Concepts; in Kaplan and Sadock’s Comprehensive Textbook of Psychiatry/VIIIth ed. Eds: Sadock BJ and Sadock VA, Lippincott Williams and Wilkins, Philadelphia, 2005
- Messias E, Tek C, Kirkpatrick B. Letter to the editor. Substance abuse and the heterogeneity of schizophrenia a population-based study. Schizophrenia Research 2003, 62: 293-294. PMID: 12837529, DOI: 10.1016/s0920-9964(02)00212-8.
- Messias E, Kirkpatrick B, Bromet E, Ross D, Buchanan B, Carpenter W, Tek C, Kendler K, Walsh D. Summer birth and deficit schizophrenia: A pooled analysis from five countries. Schizophrenia Research 2003, 60: 45-46. DOI: 10.1016/s0920-9964(03)80134-2.
- KIRKPATRICK B, TEK C, McCREADIE R. Dr. Kirkpatrick and Colleagues Reply. American Journal Of Psychiatry 2003, 160: 595-596. DOI: 10.1176/appi.ajp.160.3.595.
- Tek C, Gold J, Blaxton T, Wilk C, McMahon RP, Buchanan RW. Visual Perceptual and Working Memory Impairments in Schizophrenia. JAMA Psychiatry 2002, 59: 146-153. PMID: 11825136, DOI: 10.1001/archpsyc.59.2.146.
- Tek C, Ulug B. Religiosity and religious obsessions in obsessive–compulsive disorder. Psychiatry Research 2001, 104: 99-108. PMID: 11711164, DOI: 10.1016/s0165-1781(01)00310-9.
- TEK C, KIRKPATRICK B, KELLY C, MCCREADIE R. Summer Birth and Deficit Schizophrenia in Nithsdale, Scotland. The Journal Of Nervous And Mental Disease 2001, 189: 613-617. PMID: 11580005, DOI: 10.1097/00005053-200109000-00007.
- Tek C, Kirkpatrick B, Buchanan RW. A five-year followup study of deficit and nondeficit schizophrenia. Schizophrenia Research 2001, 49: 253-260. PMID: 11356586, DOI: 10.1016/s0920-9964(00)00146-8.
- Tek C, Uluǧ B, Rezaki B, Tanriverdi N, Mercan S, Demir B, Vargel S. Yale‐Brown Obsessive Compulsive Scale and US National Institute of Mental Health Global Obsessive Compulsive Scale in Turkish: reliability and validity. Acta Psychiatrica Scandinavica 1995, 91: 410-413. PMID: 7676839, DOI: 10.1111/j.1600-0447.1995.tb09801.x.
Biography
Cenk Tek, MD, is a psychiatrist with a focus on treating individuals with psychotic disorders. He specializes in treating conditions such as schizophrenia and bipolar disorder, providing a comprehensive range of treatments that include medication management and psychosocial interventions designed to stabilize symptoms and promote long-term recovery.
Dr. Tek’s research involves exploring the most effective treatments for psychotic disorders. He has been involved in developing and refining early intervention services for individuals experiencing their first episode of psychosis, and he works on improving clinical outcomes for these patients.
Dr. Tek received his medical training from Hacettepe University Faculty of Medicine in Turkey. He completed his residency and psychiatry fellowship at Yale School of Medicine.
Titles
- Professor of Psychiatry
- Director, Psychosis Program, CMHC
Education & Training
- MDHacettepe University Faculty of Medicine (1991)
Languages Spoken
- English
- Türkçe (Turkish)
Additional Information
Publications
- Grilo C, Ivezaj V, Tek C, Yurkow S, Wiedemann A, Gueorguieva R. Cognitive Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge-Eating Disorder With Obesity: A Randomized Controlled Trial. American Journal Of Psychiatry 2024 PMID: 39659158, DOI: 10.1176/appi.ajp.20230982.
- Grilo C, Ivezaj V, Yurkow S, Tek C, Wiedemann A, Gueorguieva R. Lisdexamfetamine maintenance treatment for binge-eating disorder following successful treatments: randomized double-blind placebo-controlled trial. Psychological Medicine 2024, 54: 3334-3344. PMID: 39258475, PMCID: PMC11496227, DOI: 10.1017/s003329172400148x.
- Hazan H, Ferrara M, Riley S, Li F, Zhou B, Kline E, Gibbs-Dean T, Karmani S, Tayfur S, Tek C, Keshavan M, Srihari V. The impact of early detection (ED) campaigns on care presentations: Beyond DUP reduction. Schizophrenia Research 2024, 264: 457-461. PMID: 38266513, PMCID: PMC10923115, DOI: 10.1016/j.schres.2024.01.022.
- Ferrara M, Guloksuz S, Hazan H, Li F, Tek C, Sykes L, Riley S, Keshavan M, Srihari V. The effect of duration of untreated psychosis (DUP) on the risk for hospitalization after admission to a first episode service. Schizophrenia Research 2023, 260: 198-204. PMID: 37688984, DOI: 10.1016/j.schres.2023.08.005.
- Srihari V, Ferrara M, Li F, Kline E, Gülöksüz S, Pollard J, Cahill J, Mathis W, Sykes L, Walsh B, McDermott G, Seidman L, Gueorguieva R, Woods S, Tek C, Keshavan M. Corrigendum to: Reducing the Duration of Untreated Psychosis (DUP) in a US Community: A Quasi-Experimental Trial. Schizophrenia Bulletin Open 2022, 3: sgac020. PMID: 39144776, PMCID: PMC11206056, DOI: 10.1093/schizbullopen/sgac020.
- Srihari V, Ferrara M, Kline E, Li F, Burke S, Cahill J, Guloksuz S, Woods S, Tek C, Keshavan M. O1.2. REDUCING THE DURATION OF UNTREATED PSYCHOSIS IN A U.S. CATCHMENT: THE MINDMAP CAMPAIGN. Schizophrenia Bulletin 2020, 46: s1-s1. PMCID: PMC7233978, DOI: 10.1093/schbul/sbaa028.001.
- Choi J, Taylor B, Fiszdon J, Astur R, Haber L, Shagan D, Tek C, Kurtz M, Pearlson G. 31.1 COMBINING EXERCISE PHYSIOLOGY, RECREATIONAL THERAPY, VIRTUAL REALITY GAMING TECHNOLOGY, AND PSYCHOSOCIAL REHABILITATION TO PROMOTE PHYSICAL EXERCISE IN SERIOUS MENTAL ILLNESS. Schizophrenia Bulletin 2019, 45: s139-s140. PMCID: PMC6455379, DOI: 10.1093/schbul/sbz022.127.
- Kucukgoncu S, Guloksuz S, Tek C. Effects of Curcumin on Cognitive Functioning and Inflammatory State in Schizophrenia. Journal Of Clinical Psychopharmacology 2019, 1. DOI: 10.1097/00004714-900000000-98602.
- Kucukgoncu S, Zhou E, Lucas K, Tek C. Alpha‐lipoic acid (ALA) as a supplementation for weight loss: results from a meta‐analysis of randomized controlled trials. Obesity Reviews 2017, 18: 594-601. PMID: 28295905, PMCID: PMC5523816, DOI: 10.1111/obr.12528.
- Srihari V, Guloksuz S, Li F, Tek C, Woods S, Pollard J, Cahill J, Keshavan M, Seidman L. 178.3 Mindmap: A Population-Based Approach to Early Detection of Psychosis in the United States. Schizophrenia Bulletin 2017, 43: s95-s95. PMCID: PMC5475714, DOI: 10.1093/schbul/sbx021.255.
- Choi J, Taylor B, Tek C, Kurtz M, Fiszdon J, Thime W, Dewberry M, Haber L, Assaf M, Pearlson G. 207. The Synergistic Effects of Physical and Cognitive Exercise in Schizophrenia. Schizophrenia Bulletin 2017, 43: s106-s106. PMCID: PMC5475743, DOI: 10.1093/schbul/sbx021.285.
- Annamalai A, Tek C, Sernyak M, Cole R, Steiner J. Integrated Health Care. 2016, 63-80. DOI: 10.1093/med/9780190214678.003.0005.
- Pollard J, Tek C, Woods S, McGlashan T, Srihari V. Early Intervention and Prevention for Psychotic Disorders. 2016, 155-170. DOI: 10.1093/med/9780190214678.003.0010.
- Ratliff J, Reutenauer E, Tek C. Managing Medication Effects on Body Weight: Do Behavioral Interventions Work? FOCUS The Journal Of Lifelong Learning In Psychiatry 2012, 10: 130-139. DOI: 10.1176/appi.focus.10.2.130.
- Tek C, Ratliff J, Chwastiak L. Pharmacological Treatment of Obesity. Psychiatric Annals 2011, 41: 489-495. DOI: 10.3928/00485713-20110921-08.
- Ratliff J, Palmese L, Reutenauer E, Liskov E, Tek C. Individuals with schizophrenia consume more calories while following a similar diet pattern as the general population. The FASEB Journal 2011, 25: 991.1-991.1. DOI: 10.1096/fasebj.25.1_supplement.991.1.
- Srihari V, Breitborde N, Pollard J, Tek C, Hyman L, Frisman L, McGlashan T, Jacobs S, Woods S. Public-Academic Partnerships: Early Intervention for Psychotic Disorders in a Community Mental Health Center. Psychiatric Services 2009, 60: 1426-1428. DOI: 10.1176/ps.2009.60.11.1426.
- Chwastiak LA, Tek C. The unchanging mortality gap for people with schizophrenia. The Lancet 2009, 374: 590-592. PMID: 19595448, DOI: 10.1016/s0140-6736(09)61072-2.
- Jean-Baptiste M, Tek C, Liskov E, Chakunta UR, Nicholls S, Hassan AQ, Brownell KD, Wexler BE. A pilot study of a weight management program with food provision in schizophrenia. Schizophrenia Research 2007, 96: 198-205. PMID: 17628437, DOI: 10.1016/j.schres.2007.05.022.
- Schizophrenia: Clinical Features and Psychopathology ConceptsKirkpatrick B, Tek C. Schizophrenia: Clinical Features and Psychopathology Concepts; in Kaplan and Sadock’s Comprehensive Textbook of Psychiatry/VIIIth ed. Eds: Sadock BJ and Sadock VA, Lippincott Williams and Wilkins, Philadelphia, 2005
- Messias E, Tek C, Kirkpatrick B. Letter to the editor. Substance abuse and the heterogeneity of schizophrenia a population-based study. Schizophrenia Research 2003, 62: 293-294. PMID: 12837529, DOI: 10.1016/s0920-9964(02)00212-8.
- Messias E, Kirkpatrick B, Bromet E, Ross D, Buchanan B, Carpenter W, Tek C, Kendler K, Walsh D. Summer birth and deficit schizophrenia: A pooled analysis from five countries. Schizophrenia Research 2003, 60: 45-46. DOI: 10.1016/s0920-9964(03)80134-2.
- KIRKPATRICK B, TEK C, McCREADIE R. Dr. Kirkpatrick and Colleagues Reply. American Journal Of Psychiatry 2003, 160: 595-596. DOI: 10.1176/appi.ajp.160.3.595.
- Tek C, Gold J, Blaxton T, Wilk C, McMahon RP, Buchanan RW. Visual Perceptual and Working Memory Impairments in Schizophrenia. JAMA Psychiatry 2002, 59: 146-153. PMID: 11825136, DOI: 10.1001/archpsyc.59.2.146.
- Tek C, Ulug B. Religiosity and religious obsessions in obsessive–compulsive disorder. Psychiatry Research 2001, 104: 99-108. PMID: 11711164, DOI: 10.1016/s0165-1781(01)00310-9.
- TEK C, KIRKPATRICK B, KELLY C, MCCREADIE R. Summer Birth and Deficit Schizophrenia in Nithsdale, Scotland. The Journal Of Nervous And Mental Disease 2001, 189: 613-617. PMID: 11580005, DOI: 10.1097/00005053-200109000-00007.
- Tek C, Kirkpatrick B, Buchanan RW. A five-year followup study of deficit and nondeficit schizophrenia. Schizophrenia Research 2001, 49: 253-260. PMID: 11356586, DOI: 10.1016/s0920-9964(00)00146-8.
- Tek C, Uluǧ B, Rezaki B, Tanriverdi N, Mercan S, Demir B, Vargel S. Yale‐Brown Obsessive Compulsive Scale and US National Institute of Mental Health Global Obsessive Compulsive Scale in Turkish: reliability and validity. Acta Psychiatrica Scandinavica 1995, 91: 410-413. PMID: 7676839, DOI: 10.1111/j.1600-0447.1995.tb09801.x.